When planning a clinical research study intended to support an FDA submission , sponsors often encounter terms such as multi-site, multi-investigator , and single-site, multiple-location . While these models may appear operationally similar, they differ in oversight structure, execution, and how evidence is evaluated by the FDA—particularly for cuffless blood pressure devices . Understanding these distinctions is essential for aligning trial design with FDA expectations and w

In every clinical research study, trust forms the foundation of participant engagement and sponsor confidence. At Parameters Research Laboratory (PRL), we recognize that protecting Personally Identifiable Information (PII)  and Protected Health Information (PHI)  is not only an ethical obligation but also a critical component of delivering regulator-ready data. Our robust privacy framework ensures participant safety, regulatory compliance, and sponsor assurance throughout eve